Regulation 256G Grant or refusal to list a personF1

(1)

On receipt of a notification from a person to be included in the list—

(a)

the F2licensing authority must include that person on the list if that person complies with the requirements in regulation 256C(2) to (5); or

(b)

if it considers necessary or appropriate to do so, the licensing authority must refuse to include that person on the list having had regard to—

(i)

the provisions of these Regulations, and

(ii)

any EU obligation.

(2)

The licensing authority must give a notice stating the reasons for its decision in any case where F3the licensing authority—

(a)

refuses to include a person on the list; or

(b)

includes a person in the list otherwise than in accordance with the notification and that person requests a statement of its reasons.

(3)

Where the licensing authority decides to include a person on the list F4the licensing authority must ensure that the F5website of the licensing authority includes—

(a)

the name or corporate name of the person that is listed; and

(b)

the person’s website address in the United Kingdom.

Annotations

Textual amendments

F1: Pt. 12A inserted (coming into force in accordance with reg. 1(2) of the amending S.I.) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(2), 28
F2: Words in regs. 256C-256M substituted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 197(4) (as substituted by S.I. 2020/1488, reg. 1, Sch. 2 para. 151); 2020 c. 1, Sch. 5 para. 1(1)
F3: Words in reg. 256G(2) substituted (31.12.2020) by S.I. 2019/775, regs. 1, 197(7)(a) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 151)
F4: Words in reg. 256G(3) substituted (31.12.2020) by S.I. 2019/775, regs. 1, 197(7)(b)(i) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 S.I. 2020/1488, reg. 1, Sch. 2 para. 151)
F5: Words in reg. 256G(3) substituted (31.12.2020) S.I. 2019/775, regs. 1, 197(7)(b)(ii) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 S.I. 2020/1488, reg. 1, Sch. 2 para. 151)